title: NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI.
authors: Medical Oncology Unit, University Hospital, Parma, Italy.
authors: Francesco
authors: F
authors: Facchinetti
authors: Marcello
authors: M
authors: Tiseo
authors: Letizia
authors: L
authors: Gnetti
authors: Enrico Maria
authors: EM
authors: Silini
authors: Andrea
authors: A
authors: Ardizzoni
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D066246:ErbB Receptors / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D055752:Small Cell Lung Carcinoma / Q000473:pathology*; D013618:Tachyphylaxis / Q000235:genetics*
chemical_list: D066246:ErbB Receptors; D010751:Phosphopyruvate Hydratase